Status:
COMPLETED
Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
Lead Sponsor:
Allergan
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
21-50 years
Phase:
PHASE2
Brief Summary
This study will evaluate the safety and efficacy of cyclosporine ophthalmic emulsion administered twice daily following LASIK surgery
Eligibility Criteria
Inclusion
- Patient is scheduled for bilateral LASIK surgery
- Patient is in good general health
- Eye glasses prescription of -1 to -8
Exclusion
- Significant Dry Eye
- Presence of eye disease
- Uncontrolled systemic disease
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT00611403
Start Date
December 1 2007
End Date
June 1 2009
Last Update
December 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Overland Park, Kansas, United States